123 related articles for article (PubMed ID: 38380874)
1. Impact of weight reduction on structural and functional parameters of the optic nerve in idiopathic intracranial hypertension.
Banerjee M; Phuljhele S; Saxena R; Sharma P; Misra V; Vibha D; Pandit AK
Eur J Ophthalmol; 2024 Feb; ():11206721241232038. PubMed ID: 38380874
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography features and correlation of functional and structural parameters in patients of idiopathic intracranial hypertension.
Banerjee M; Phuljhele S; Saluja G; Kumar P; Saxena R; Sharma P; Vibha D; Pandit AK
Indian J Ophthalmol; 2022 Apr; 70(4):1343-1349. PubMed ID: 35326052
[TBL] [Abstract][Full Text] [Related]
3. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
[TBL] [Abstract][Full Text] [Related]
4. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
[TBL] [Abstract][Full Text] [Related]
5. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
Dreesbach M; Joachimsen L; Küchlin S; Reich M; Gross NJ; Brandt AU; Schuchardt F; Harloff A; Böhringer D; Lagrèze WA
Transl Vis Sci Technol; 2020 Feb; 9(3):24. PubMed ID: 32742754
[TBL] [Abstract][Full Text] [Related]
6. Sonographic and ophthalmic assessment of optic nerve in patients with idiopathic intracranial hypertension: A longitudinal study.
Knodel S; Roemer SN; Moslemani K; Wykrota A; Käsmann-Kellner B; Seitz B; Wagenpfeil G; Fassbender K; Naldi A; Kalampokini S; Lochner P
J Neurol Sci; 2021 Nov; 430():118069. PubMed ID: 34525433
[TBL] [Abstract][Full Text] [Related]
7. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
Vosoughi AR; Margolin EA; Micieli JA
J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
[TBL] [Abstract][Full Text] [Related]
8. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Peragallo JH; Newman NJ; Biousse V
Br J Ophthalmol; 2019 Oct; 103(10):1429-1435. PubMed ID: 30530819
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema.
Huang-Link Y; Eleftheriou A; Yang G; Johansson JM; Apostolou A; Link H; Jin YP
Eur J Neurol; 2019 May; 26(5):808-e57. PubMed ID: 30586220
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Optic Disc Peripapillary Capillary Network and Papilledema Grading in Patients With Idiopathic Intracranial Hypertension: A Study of Optical Coherence Tomography Angiography.
Rodriguez Torres Y; Lee P; Mihlstin M; Tomsak RL
J Neuroophthalmol; 2021 Mar; 41(1):48-53. PubMed ID: 31972713
[TBL] [Abstract][Full Text] [Related]
11. Influence of Optic Nerve Appearance on Visual Outcome in Pediatric Idiopathic Intracranial Hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Newman NJ; Biousse V; Peragallo JH
Can J Neurol Sci; 2020 Sep; 47(5):661-665. PubMed ID: 32362301
[TBL] [Abstract][Full Text] [Related]
12. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C
Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155
[TBL] [Abstract][Full Text] [Related]
13. Weight reduction for a better visual outcome in idiopathic intracranial hypertension.
Koc F; Isik MR; Sefi-Yurdakul N
Arq Bras Oftalmol; 2018; 81(1):18-23. PubMed ID: 29538589
[TBL] [Abstract][Full Text] [Related]
14. Peripapillary microperimetry for the diagnosis and follow-up of papilledema in cases treated for idiopathic intracranial hypertension.
Elnahry GA; Elemary AM; Badr Eldin N; Nossair AA; Barrada OA; Elnahry AG
Neurol Res; 2021 Jan; 43(1):61-70. PubMed ID: 32915708
[TBL] [Abstract][Full Text] [Related]
15. The Leading Causes of Optic Disc Edema Seen in Tertiary Care, Academic Neuro-Ophthalmology Clinics.
Jhaveri A; Pandya B; Shamshad F; Soor D; Margolin E; Micieli JA
J Neuroophthalmol; 2024 Jan; ():. PubMed ID: 38214979
[TBL] [Abstract][Full Text] [Related]
16. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.
Gospe SM; Bhatti MT; El-Dairi MA
Br J Ophthalmol; 2016 Apr; 100(4):505-9. PubMed ID: 26269534
[TBL] [Abstract][Full Text] [Related]
17. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
[TBL] [Abstract][Full Text] [Related]
18. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.
Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO
J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064
[TBL] [Abstract][Full Text] [Related]
19. Optic Nerve Angle in Idiopathic Intracranial Hypertension.
Chen BS; Asnafi S; Lin MY; Bruce BB; Lock JH; Sharma RA; Newman NJ; Biousse V; Saindane AM
J Neuroophthalmol; 2021 Dec; 41(4):e464-e469. PubMed ID: 34788243
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension.
Eren Y; Kabatas N; Guven H; Comoglu S; Gurdal C
Acta Neurol Belg; 2019 Sep; 119(3):351-357. PubMed ID: 30120685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
